The extent to which product characteristics of new innovations influence nurses’ intention to advise them

The increasing spread of diabetes and its associated dangers for the health of the world’s population leave an enormous market potential for firms striving to find a cure and new solutions to this disease. Current treatment options rely on continuous patient involvement. Only recently, the Dutch company Inreda B.V. has started developing an artificial pancreas, which automates the blood glucose level monitoring as well as balancing and does not require patient involvement. In order to successfully enter the market, the aim of this research is to find out whether certain product characteristics influence the decision of nurses’ to advise a new product